Skip to main content
    Z

    Zimmer Biomet Holdings Inc (ZBH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $101.44
    -1.78 (-1.72%)

    Market Cap: $19.53B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zimmer Biomet Holdings Inc (ZBH) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Zimmer Biomet Holdings (ZBH) to earn $8.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $8.61B. Of 27 analysts, 8 rate the stock Buy or Strong Buy, 19 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 14 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 27 ratings average 2.63, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 30% of the ratings.

    RatingAnalystsShare
    Strong Buy27.4%
    Buy622.2%
    Hold1970.4%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    27

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 5.0% and revenue estimates rise 3.4%.

    Fiscal year ending Dec 31, 2026
    $8.55
    EPS consensus, revenue $8.61B
    Fiscal year ending Dec 31, 2027
    $8.98
    EPS consensus, revenue $8.90B
    Next report
    Feb 8, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$8.55$8.30 to $8.6027$8.61B$8.60B to $8.63B25
    Dec 31, 2027$8.98$8.68 to $9.3227$8.90B$8.83B to $8.99B25

    Quarterly Estimates

    The EPS consensus falls from $2.51 for the quarter ending Dec 31, 2026 to $2.08 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.51$2.39 to $2.6726$2.31B$2.23B to $2.42B25
    Mar 31, 2027$2.08$2.00 to $2.1818$2.15B$2.12B to $2.17B13

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 26 upward and 21 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026143
    Fiscal year ending Dec 31, 2027514
    Quarter ending Mar 31, 202774

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.2% from $8.53.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$8.55$8.54$8.53$8.53$8.53+0.1%
    Fiscal year ending Dec 31, 2027$8.98$9.05$9.07$9.07$9.07-1.0%
    Quarter ending Mar 31, 2027$2.08$2.11$2.12$2.12$2.12-1.8%

    Frequently Asked Questions About ZBH

    What is the ZBH stock forecast?

    Consensus analyst estimates put Zimmer Biomet Holdings's EPS at $8.55 for the fiscal year ending Dec 31, 2026, on revenue of $8.61B. The consensus rating from 27 analysts is Hold.

    How do analysts rate ZBH stock?

    Of 27 analysts covering Zimmer Biomet Holdings, 2 rate it Strong Buy, 6 Buy, 19 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from ZBH next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $8.55, with estimates from $8.30 to $8.60 from 27 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $8.98, with estimates from $8.68 to $9.32 from 27 analysts.

    What revenue do analysts expect from Zimmer Biomet Holdings next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $8.61B, with estimates from $8.60B to $8.63B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $8.90B, with estimates from $8.83B to $8.99B.

    How many analysts cover ZBH?

    27 analysts rate Zimmer Biomet Holdings stock, and 27 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.